Patient with heparin-induced thrombocytopenia type II and implanted left ventricular assist device;Patient mit heparininduzierter thrombozytopenie typ II und implantiertem linksventrikulärem assistdevice

Anaesthesist

Volumn 57, Issue 1, 2008, Pages 49-52

  Lutz, J T ^a   Exner, H J ^a   Schannewitzky, A ^a   Fehske, W ^a   Gorlinger K ^b  

^a ST VINZENZ HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Argatroban; Cardiomyopathy; Heparin induced thrombocytopenia; Partial thromboplastin time International normalized ratio; Renal insufficiency

Indexed keywords

ARGATROBAN; HEPARIN; HEPARIN PLATELET FACTOR 4 ANTIBODY; THROMBOPLASTIN;

HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; REVIEW; THROMBOSIS;

AGED; ANTICOAGULANTS; FEMALE; HEART-ASSIST DEVICES; HEPARIN; HUMANS; PARTIAL THROMBOPLASTIN TIME; PIPECOLIC ACIDS; PLATELET AGGREGATION INHIBITORS; PLATELET FACTOR 4; THROMBOCYTOPENIA;

EID: 38749113894     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1297-3     Document Type: Review

References (9)

1. Beiderlinden M, Treschan TA, Görlinger K, Peters J (2007) Argatroban anticoagulation in critically ill patients. Ann Pharmacother 41(5): 749-754
2. Hein OV, Heymann C von, Morgera S et al. (2005) Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failure. Artif Organs 29(6): 507-510
3. Hinz P, Lubenow N, Ekkernkamp A, Greinacher A (2003) Aufklärung über die Heparin-induzierte Thrombozytopenie im Rahmen der Thromboseprophylaxe mit Heparin. Dtsch Med Wochenschr 128: 2184-2188
4. Lubenow N, Selleng S, Wollert HG et al. (2003) Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use. Ann Thorac Surg 75(2): 577-579
5. Sheth SB, DiCicco RA, Hursting MJ et al. (2001) Interpreting the International Normalized Ratio (INR) in individuals receiving argatroban and warfarin. Thromb Haemost 85(3): 435-440
6. Swan SK, Hursting MJ (2000) The pharmacokinetics and pharmacodynamics of argatroban: effects of age, gender, and hepatic or renal dysfunction. Pharmacotherapy 20(3): 318-329
7. Wallis DE, Quintos R, Wehrmacher W, Messmore H (1999) Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia. Chest 116(5): 1333-1338
8. Warkentin TE (2001) Clinical picture of heparin-induced thrombocytopenia. In: Warkentin TE, Greinacher A (eds) Heparin-induced thrombocytopenia, 2nd edn. Dekker, New York, pp 43-86
9. Williamson DR, Boulanger I, Tardif M et al. (2004) Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction. Pharmacotherapy 24(3): 409-414